Report - Alicja Kalinowska · 2014 2016 sc IFNβ-1b im IFNβ-1a sc IFNβ-1b GA 20 mg/ml natalizumab fingolimod Fumaran dimetylu Peg IFNβ-1a GA 40 mg/ml Alemtuzumab Teriflunomid 2017 Daclizumab

Please pass captcha verification before submit form